Excellent - I now have rich textbook material. Let me compile a complete, pure-education answer covering every test on that chart - purpose, enzymes, cycles, and causes of high/low.
Complete Investigation Guide: Purpose, Enzymes, Cycles & Clinical Significance
(Pure education - no patient results discussed)
PART 1: COMPLETE BLOOD COUNT (CBC)
1. Hb% (Hemoglobin)
What it measures: The oxygen-carrying protein inside red blood cells.
Normal values: Males 13-18 g/dL | Females 12-15 g/dL
Purpose: Diagnoses anemia and polycythemia; assesses oxygen-carrying capacity of blood.
Biochemical Structure:
- Each hemoglobin molecule has 4 globin chains (2 alpha + 2 beta in adult HbA) + 4 heme groups
- Each heme = iron (Fe²⁺) + protoporphyrin IX ring - one Fe²⁺ binds one O₂ molecule
- Total: 1 Hb molecule carries 4 oxygen molecules
Heme Synthesis Cycle (in mitochondria + cytoplasm of erythroblasts):
Glycine + Succinyl-CoA
↓ [ALA synthase - rate-limiting enzyme, needs Pyridoxal phosphate/B6]
δ-Aminolevulinic acid (ALA)
↓ [ALA dehydratase]
Porphobilinogen (PBG)
↓ [multiple enzymes]
Uroporphyrinogen III
↓
Coproporphyrinogen III
↓
Protoporphyrin IX
↓ + Fe²⁺ [Ferrochelatase - inserts iron, last step]
HEME
↓ + Globin chains
HEMOGLOBIN
Key enzymes: ALA synthase (rate-limiting), ALA dehydratase (inhibited by lead), ferrochelatase (inhibited by lead)
Why RAISED (Polycythemia):
- High altitude (compensatory, low O₂ → ↑ EPO → ↑ RBC production)
- Polycythemia vera (myeloproliferative disorder)
- Chronic hypoxia (COPD, cyanotic heart disease)
- Dehydration (relative/spurious)
Why LOWERED (Anemia):
- Decreased production: iron deficiency (↓ heme synthesis), B12/folate deficiency (↓ DNA synthesis), renal failure (↓ erythropoietin), aplastic anemia
- Increased destruction (hemolysis): malaria, G6PD deficiency, sickle cell, autoimmune hemolytic anemia
- Blood loss: acute (trauma, surgery) or chronic (GI bleed, menorrhagia)
2. WBC's (White Blood Cell Count)
What it measures: Total count of all immune cells in blood.
Normal: 5000-10,000 Cu/mm
Purpose: Screens for infection, inflammation, hematological malignancy, immunosuppression.
The 5 Cell Types and Their Roles:
| Cell | % of WBC | Origin | Key Role | Enzyme/Mediator Used |
|---|
| Neutrophils | 60-70% | Bone marrow myeloid lineage | Kill bacteria/fungi via phagocytosis | Myeloperoxidase, NADPH oxidase (oxidative burst) |
| Lymphocytes | 20-30% | Lymphoid lineage | B cells: make antibodies; T cells: kill viruses/cancer | Lymphokines, perforin, granzymes |
| Monocytes | 2-8% | Bone marrow | Phagocytosis; differentiate into macrophages in tissue | Lysozyme, cathepsins |
| Eosinophils | 1-4% | Bone marrow | Destroy parasites; mediate allergic reactions | Major basic protein, eosinophil peroxidase |
| Basophils | 0.5-1% | Bone marrow | Allergic/anaphylactic responses | Histamine, heparin (stored in granules) |
Why RAISED (Leukocytosis):
- Bacterial infection (neutrophilia with left shift = bands/immature forms)
- Viral infection (lymphocytosis)
- Allergic reactions, parasites (eosinophilia)
- Leukemia (uncontrolled proliferation)
- Steroids, adrenaline/stress (demargination of neutrophils)
- Tissue necrosis (MI, burns)
Why LOWERED (Leukopenia):
- Viral infections (HIV, EBV, dengue - destroy lymphocytes/bone marrow)
- Chemotherapy, radiation
- Aplastic anemia, hypersplenism
- Autoimmune: SLE (anti-neutrophil antibodies)
- Severe sepsis (consumption)
3. Platelets
What it measures: Number of thrombocytes - small cell fragments involved in clotting.
Normal: 1,50,000 - 4,50,000 Cu/mm
Purpose: Screens for bleeding disorders or thrombotic risk.
Platelet Lifecycle:
Pluripotent stem cell
↓ [Thrombopoietin (TPO) from liver/kidney]
Megakaryocyte precursor
↓
Megakaryocyte (large cell in bone marrow)
↓ [fragments its cytoplasm]
Platelets released into blood (lifespan: 7-10 days)
↓ [when vessel is injured]
Platelet activation (collagen → vWF → GPIb receptor binding)
↓
Shape change + release of ADP, TXA₂, serotonin from granules
↓ [GPIIb/IIIa receptor activated]
Fibrinogen bridges platelets → PRIMARY PLATELET PLUG
↓
Old platelets removed by spleen macrophages
Key enzymes in activation: Cyclooxygenase (COX-1) → thromboxane A₂ (TXA₂); Phospholipase C; Adenylyl cyclase
Why RAISED (Thrombocytosis >4,50,000):
- Reactive (most common): infection, inflammation, iron deficiency anemia, post-splenectomy, post-surgery, malignancy
- Primary: Essential thrombocythemia (bone marrow disorder)
Why LOWERED (Thrombocytopenia <1,50,000):
- Decreased production: aplastic anemia, B12/folate deficiency, leukemia, bone marrow suppression, alcohol, liver disease (↓ TPO)
- Increased destruction: ITP (autoimmune antibodies destroy platelets), DIC (consumptive), TTP (platelet thrombi form everywhere), heparin-induced thrombocytopenia (HIT)
- Sequestration: hypersplenism (spleen traps platelets)
- Dilutional: massive transfusion
4. ESR (Erythrocyte Sedimentation Rate)
What it measures: Speed at which red blood cells fall to the bottom of a tube (mm in 1 hour).
Normal: Females 0-15 mm/hr | Males 0-20 mm/hr
Purpose: Nonspecific marker of systemic inflammation.
Mechanism:
- Normally, RBCs repel each other due to negative surface charge (from sialic acid on glycophorin)
- In inflammation, acute-phase proteins (fibrinogen, immunoglobulins, CRP) are released by the liver
- These proteins coat RBCs, reducing the repulsive charge → RBCs form rouleaux (stack like coins)
- Rouleaux formation → heavier aggregates → fall faster → high ESR
Causes of RAISED ESR:
- Inflammation (any cause): infection, autoimmune (RA, SLE, polymyalgia rheumatica), IBD
- Malignancy (especially multiple myeloma - huge amounts of immunoglobulins)
- Anemia (fewer RBCs to repel each other)
- Pregnancy, obesity
Causes of FALSELY LOW ESR (RBCs can't form rouleaux):
- Polycythemia vera (too many RBCs, pack immediately)
- Sickle cell disease (abnormal shape prevents rouleaux)
- Spherocytosis
- Extreme leukocytosis
PART 2: RENAL FUNCTION TESTS
5. BSL (Blood Sugar Level / Fasting Blood Glucose)
Normal: 70-120 mg/dL (fasting)
Purpose: Diagnoses diabetes mellitus, hypoglycemia, and monitors glucose control.
Glucose Metabolic Cycle:
Dietary glucose absorbed → blood
↓ [Insulin from beta cells of pancreas → GLUT4 transporters open]
Enters cells → GLYCOLYSIS (cytoplasm)
Glucose → G6P → F6P → ... → 2 Pyruvate + 2 ATP + 2 NADH
↓ [Pyruvate dehydrogenase, needs B1/thiamine - irreversible]
Acetyl-CoA enters mitochondria
↓
KREBS CYCLE (TCA cycle) → 8 NADH + 2 FADH₂ + 2 GTP per glucose
↓
OXIDATIVE PHOSPHORYLATION → 30-32 ATP total per glucose
Regulation enzymes (key):
- Hexokinase/Glucokinase - phosphorylates glucose (traps it in cell)
- Phosphofructokinase-1 (PFK-1) - rate-limiting step of glycolysis (inhibited by ATP, activated by AMP)
- Pyruvate kinase - last step of glycolysis
- Pyruvate dehydrogenase - gateway to Krebs cycle (needs B1, B2, B3, lipoate, CoA)
Why RAISED (Hyperglycemia):
- Type 1 DM (no insulin - autoimmune beta cell destruction)
- Type 2 DM (insulin resistance)
- Pancreatitis (destruction of islets of Langerhans)
- Cushing's syndrome (cortisol is counter-regulatory)
- Acromegaly, pheochromocytoma, glucagonoma
- Drugs: steroids, thiazides, atypical antipsychotics
Why LOWERED (Hypoglycemia):
- Insulin overdose (most common clinical cause)
- Prolonged fasting, malnutrition
- Insulinoma (tumor secreting insulin)
- Addison's disease (no cortisol → no gluconeogenesis)
- Alcohol (blocks gluconeogenesis)
- Severe liver disease (liver can't make glucose)
6. BUL (Blood Urea Level) / BUN (Blood Urea Nitrogen)
Normal: 12-45 mg/dL
Purpose: Reflects the kidney's ability to excrete the end-product of protein metabolism. Elevated BUN = kidneys not clearing waste OR excess protein load.
The Urea Cycle (occurs in liver):
Amino acids deaminated → NH₃ (ammonia) - highly toxic to CNS
↓
NH₃ + CO₂ + 2 ATP → Carbamoyl phosphate
[Carbamoyl phosphate synthetase I - rate-limiting, in mitochondria]
↓
Carbamoyl phosphate + Ornithine → Citrulline
[Ornithine transcarbamylase - mitochondria]
↓ Citrulline exits to cytoplasm
Citrulline + Aspartate → Argininosuccinate
[Argininosuccinate synthetase]
↓
Argininosuccinate → Arginine + Fumarate
[Argininosuccinase]
↓
Arginine → Urea + Ornithine (ornithine returns to mitochondria to restart cycle)
[Arginase - final step]
↓
Urea travels in blood → kidneys → filtered and excreted in urine
Why RAISED (Azotemia):
- Pre-renal (most common): dehydration, heart failure, shock, GI bleed (blood protein absorbed)
- Renal: AKI, CKD, glomerulonephritis
- Post-renal: urinary obstruction (prostate, stones)
- High protein diet, catabolic states
Why LOWERED:
- Liver failure (urea cycle enzymes absent - can't convert ammonia to urea → ammonia accumulates → hepatic encephalopathy)
- Malnutrition, low protein diet
- Pregnancy (increased GFR clears more urea)
- SIADH (dilution)
7. Sr. Creatinine
Normal: 0.7-1.4 mmol/L
Purpose: The best single marker of GFR (glomerular filtration rate). More reliable than BUN because it is not affected by diet or liver function.
Biochemical Cycle:
Skeletal muscle uses Creatine phosphate as an energy buffer:
Creatine + ATP ⇌ Creatine phosphate + ADP [Creatine kinase]
Creatine phosphate undergoes spontaneous, irreversible, non-enzymatic cyclization:
Creatine phosphate → Creatinine (constant, daily rate proportional to muscle mass)
Creatinine → enters blood → kidney → freely filtered by glomerulus (not reabsorbed,
small amount secreted by tubules) → excreted in urine
As Miller's Anesthesia states: "Creatinine is an end product of skeletal muscle catabolism and is excreted solely by the kidneys."
Important points:
- Creatinine rises LATE in kidney disease (serum creatinine doubles only when ~50% of GFR is lost)
- Creatinine reflects muscle mass - values must be interpreted relative to body build
Why RAISED:
- AKI or CKD (kidneys can't filter it out)
- Rhabdomyolysis (huge muscle breakdown releases creatinine suddenly)
- High red meat diet (dietary creatine converts to creatinine)
- Drugs: trimethoprim, cimetidine (block tubular secretion of creatinine - apparent rise, not true GFR change)
Why LOWERED:
- Reduced muscle mass (elderly, malnutrition, cachexia, paraplegia)
- Pregnancy (GFR increases by 50% → more filtration)
- Severe liver disease (decreased creatine synthesis in liver)
- Vegetarian diet
8. Sr. Na⁺ (Sodium) | Sr. K⁺ (Potassium) | Sr. Cl⁻ (Chloride)
Sodium (Normal 135-145 mmol/L):
Purpose: Controls plasma osmolality and extracellular fluid volume. The most important extracellular cation.
Regulation: Renin-Angiotensin-Aldosterone System (RAAS) + ADH (antidiuretic hormone)
- Low blood pressure → Renin → Angiotensin I → ACE → Angiotensin II → Aldosterone → Na⁺ reabsorption in distal tubule/collecting duct (via ENaC channels + Na/K-ATPase)
- ADH (from posterior pituitary) → aquaporin-2 channels open → water reabsorption → dilutes Na⁺
Hyponatremia (<135) causes: SIADH (excess ADH), heart failure, cirrhosis, nephrotic syndrome (dilutional), Addison's disease (↓ aldosterone), hypothyroidism, diuretics, vomiting/diarrhea
Hypernatremia (>145) causes: Dehydration/water loss, diabetes insipidus (no ADH → lose free water), Conn's syndrome (excess aldosterone), fever, burns
Potassium (Normal 3.8-5 mmol/L):
Purpose: Primary intracellular cation - determines resting membrane potential of heart and nerve/muscle cells. Critical for cardiac rhythm.
Regulation:
- Aldosterone: ↑ K⁺ excretion in kidney
- Insulin: drives K⁺ into cells (via Na/K-ATPase)
- pH: acidosis → K⁺ exits cells (H⁺ goes in, K⁺ comes out) → hyperkalemia; alkalosis → hypokalemia
Hypokalemia (<3.5) causes: Vomiting/diarrhea (most common), diuretics (loop/thiazide), Conn's syndrome (↑ aldosterone), Cushing's, insulin therapy, alkalosis, β₂ agonists (salbutamol)
- ECG changes: U waves, ST depression, prolonged QT
Hyperkalemia (>5.5) causes: Renal failure (can't excrete K⁺), Addison's disease, ACE inhibitors/ARBs, K-sparing diuretics, rhabdomyolysis, hemolysis, acidosis, succinylcholine
- ECG changes: peaked T waves → wide QRS → sine wave → VF/asystole (fatal if untreated)
Chloride (Normal 95-105 mmol/L):
Purpose: Main extracellular anion; maintains electrical neutrality with sodium; important for acid-base balance.
Why RAISED (Hyperchloremia): Metabolic acidosis (hyperchloremic type), dehydration, excessive NaCl infusion, renal tubular acidosis
Why LOWERED (Hypochloremia): Vomiting (loss of HCl), metabolic alkalosis, SIADH, diuretics, Addison's disease
PART 3: LIVER FUNCTION TESTS (LFTs)
9. SGOT / AST (Serum Glutamic Oxaloacetic Transaminase)
Normal: 10-40 U/L
Purpose: Marker of hepatocellular damage. Less specific to liver than ALT.
Enzyme Function:
AST catalyzes transamination - transfers amino groups between amino acids and keto-acids, connecting amino acid metabolism to the Krebs cycle:
Aspartate + α-Ketoglutarate ⇌ Oxaloacetate + Glutamate
[AST/SGOT]
- This feeds oxaloacetate into the Krebs cycle
- Cofactor required: Pyridoxal phosphate (Vitamin B6) - forms a Schiff base intermediate
- Location: Both cytoplasm AND mitochondria of hepatocytes, cardiac muscle, skeletal muscle, kidney, brain
- Mitochondrial AST rises especially in alcoholic liver disease (alcohol damages mitochondria)
Why RAISED:
- Liver: viral hepatitis, alcoholic hepatitis (AST:ALT ratio >2), cirrhosis, fatty liver, drug-induced liver injury (anti-TB drugs, paracetamol, statins), ischemic hepatitis
- Cardiac: myocardial infarction (rises 6-8 hrs, peaks 24-48 hrs)
- Muscle: rhabdomyolysis, polymyositis, muscular dystrophy, strenuous exercise
- Hypothyroidism, hemolysis, celiac disease
Why LOWERED: Not clinically significant. Can be falsely low in Vitamin B6 deficiency (needs B6 as cofactor), severe end-stage liver disease (no hepatocytes left), uremia.
10. SGPT / ALT (Serum Glutamic Pyruvic Transaminase)
Normal: 5-35 U/L
Purpose: Most specific marker of liver cell injury. Called the "liver enzyme" because it is predominantly hepatic.
Enzyme Function:
Alanine + α-Ketoglutarate ⇌ Pyruvate + Glutamate
[ALT/SGPT]
- This reaction links amino acid metabolism to glycolysis/gluconeogenesis (via pyruvate)
- Cofactor: Pyridoxal phosphate (Vitamin B6)
- Location: Cytoplasm only (not mitochondria)
- Found mainly in liver (much less in skeletal muscle, kidney)
- More specific for liver than AST
AST:ALT Ratio (De Ritis Ratio) - Key Diagnostic Tool:
| Ratio | Pattern | Likely Cause |
|---|
| <1 (ALT > AST) | Hepatocellular | Viral hepatitis, NAFLD, drug hepatitis |
| >2 (AST >> ALT) | Alcoholic / mitochondrial damage | Alcoholic hepatitis, Wilson's disease |
| Both >10x normal | Massive necrosis | Paracetamol overdose, ischemic hepatitis, fulminant viral hepatitis |
Why RAISED: Same hepatic causes as AST, but ALT elevation is more liver-specific. Also in celiac disease (enterocytes contain ALT), thyroid disease.
Why LOWERED: Same as AST (B6 deficiency, uremia, end-stage liver disease).
11. Total Bilirubin / Direct Bilirubin / Indirect Bilirubin
Normal: Total 0.1-1.2 mg/dL | Direct 0.1-0.4 | Indirect 0.1-0.6 mg/dL
Purpose: Assesses liver's ability to process hemoglobin breakdown product. Elevated bilirubin causes jaundice (>2.5 mg/dL visible in sclera/skin).
The Bilirubin Metabolic Pathway:
RBC destruction (lifespan 120 days, spleen)
↓
Hemoglobin released → heme + globin
↓
Heme → Biliverdin (green)
[Heme oxygenase - in reticuloendothelial cells: spleen, liver, bone marrow]
↓
Biliverdin → UNCONJUGATED BILIRUBIN (indirect) - lipid-soluble, TOXIC
[Biliverdin reductase]
↓
Binds albumin in blood (non-covalently) → transported to liver
IN LIVER HEPATOCYTES:
↓ [Uptake by OATP1B1/1B3 transporters]
Unconjugated bilirubin + 2× Glucuronic acid → CONJUGATED BILIRUBIN (direct) - water-soluble, NON-TOXIC
[B-UGT: Bilirubin UDP-glucuronosyltransferase - in endoplasmic reticulum]
↓
Excreted into bile canaliculi [MRP2/ABCC2 transporter - rate-limiting step]
↓
Bile → duodenum → Urobilinogen (by gut bacteria)
↓ ↓
Excreted in stool Reabsorbed (enterohepatic circulation)
as Stercobilin ↓
(brown colour) Small amount → kidney → urine as Urobilin (yellow colour)
Types of Jaundice and Bilirubin Pattern:
| Type | Total | Direct | Indirect | Urine Bilirubin | Urobilinogen |
|---|
| Pre-hepatic (hemolysis) | ↑ | Normal | ↑↑ | Absent | ↑↑ |
| Hepatic (hepatitis) | ↑↑ | ↑ | ↑ | Present | Variable |
| Post-hepatic (cholestasis/obstruction) | ↑↑ | ↑↑ | Normal | Present (dark urine) | Absent |
Why RAISED:
- Pre-hepatic: hemolysis (malaria, G6PD deficiency, sickle cell, spherocytosis), Gilbert's syndrome (UGT1A1 mutation - harmless)
- Hepatic: viral hepatitis, alcoholic liver disease, drugs (rifampicin, paracetamol), cirrhosis, Crigler-Najjar syndrome (absent UGT1A1)
- Post-hepatic: gallstones in CBD, cholangiocarcinoma, carcinoma head of pancreas, primary sclerosing cholangitis
12. Sr. Proteins (Total) | Sr. Albumin | Globulin
Normal: Total protein 5.5-8.0 g/dL | Albumin 3.5-5 g/dL | Globulin 1.5-3 g/dL | A/G ratio >1
Purpose: Assesses liver synthetic function and nutritional status.
Albumin:
- Synthesized exclusively in hepatocytes (liver), half-life ~20 days
- Functions: maintains colloid oncotic pressure (keeps fluid in blood vessels), transports bilirubin, fatty acids, thyroid hormones, drugs (warfarin, aspirin), calcium, zinc
Why albumin LOWERED:
- Reduced synthesis: chronic liver disease (cirrhosis - most important), malnutrition
- Increased loss: nephrotic syndrome (leaks through damaged glomeruli into urine), protein-losing enteropathy
- Dilution: third-trimester pregnancy, overhydration
- Increased consumption: severe sepsis, burns, trauma (albumin is a negative acute-phase reactant - liver prioritizes making CRP/fibrinogen during inflammation instead)
Globulins (comprise immunoglobulins + transport proteins + complement):
Why RAISED: Chronic infections (TB, malaria, brucellosis), cirrhosis (polyclonal), multiple myeloma (monoclonal spike = M-band), autoimmune diseases (SLE, RA)
Why LOWERED: Immunodeficiency syndromes, protein malnutrition
A/G Ratio reversal (<1): Chronic liver disease (↓ albumin + ↑ globulins), multiple myeloma, nephrotic syndrome
13. Alk. Phosphatase (ALP)
Normal: 70-251 U/L
Purpose: Marker of cholestatic liver disease or bone disease.
Enzyme Function: ALP removes phosphate groups from substrates (hydrolysis of phosphate esters). Role in biliary epithelium: transport of lipids, bile salts. Role in bone: facilitates mineralization by hydrolyzing pyrophosphate (an inhibitor of hydroxyapatite crystal formation).
Sources (Isoforms):
| Isoform | Source | Clinical Context |
|---|
| Liver ALP | Biliary canaliculi | Cholestasis, bile duct obstruction |
| Bone ALP | Osteoblasts | Bone diseases (Paget's, metastases, fractures) |
| Intestinal ALP | Small bowel | Post-meal rise (blood group B/O) |
| Placental ALP | Placenta | Normal pregnancy (3rd trimester) |
| Regan isoform | Tumor cells | Malignancy (lung, ovary) |
How to distinguish Liver vs Bone source: Check GGT (gamma-glutamyl transferase) - if GGT is also elevated, source is liver; if GGT is normal, source is bone.
Why RAISED:
- Liver/biliary: cholestasis, primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), bile duct stones/tumor, drug-induced cholestasis
- Bone: Paget's disease of bone, bone metastases, osteosarcoma, hyperparathyroidism (increased osteoclast + osteoblast activity), osteomalacia (healing), growing children (physiological)
- Pregnancy, liver malignancy
Why LOWERED: Hypothyroidism, zinc deficiency, pernicious anemia (B12 deficiency), hypophosphatasia (genetic ALP deficiency - rare but causes soft bones in children)
14. Protime / PT (Prothrombin Time)
Normal: 10-14 seconds (II, VII, X)
Purpose: Tests the extrinsic + common pathways of coagulation. Also used to monitor Vitamin K status and warfarin therapy (expressed as INR = Patient PT / Mean Normal PT).
The Coagulation Cascade:
EXTRINSIC PATHWAY (tested by PT):
Tissue damage → Tissue Factor (TF/Factor III) released
TF + Factor VII (+ Ca²⁺) → TF-VIIa complex
↓ activates
Factor X → Xa
INTRINSIC PATHWAY (tested by APTT):
XII → XIIa → XI → XIa → IX → IXa (+VIIIa, Ca²⁺, phospholipid) → Xa
COMMON PATHWAY (tested by both PT and APTT):
Xa + Va + Ca²⁺ + phospholipid → Prothrombinase complex
Prothrombin (II) → Thrombin (IIa) [Prothrombinase]
Fibrinogen (I) → Fibrin (Ia) [Thrombin]
Fibrin monomers → cross-linked fibrin clot [Factor XIIIa + Thrombin]
Vitamin K-dependent factors (synthesized in liver, need Vit K for gamma-carboxylation): II, VII, IX, X (and Protein C, S)
- Warfarin blocks Vitamin K epoxide reductase → ↓ these factors → ↑ PT
Why PT PROLONGED:
- Liver disease (can't synthesize clotting factors)
- Vitamin K deficiency (malabsorption, newborn - gives neonatal Vit K injection)
- Warfarin therapy
- DIC (consumptive coagulopathy)
- Factor deficiencies (II, V, VII, X)
15. BT (Bleeding Time) and CT (Clotting Time)
| Test | What it tests | Normal |
|---|
| BT (Bleeding Time) | Platelet function + vascular plug (primary hemostasis) | 2-7 seconds |
| CT (Clotting Time) | Whole blood clotting - intrinsic pathway | 5-10 seconds |
BT prolonged: Thrombocytopenia, von Willebrand disease, aspirin/NSAIDs (inhibit COX-1 → no TXA₂ → impaired platelet aggregation), Glanzmann's thrombasthenia
CT prolonged: Hemophilia A (Factor VIII deficiency), Hemophilia B (Factor IX deficiency), heparin therapy, DIC
PART 4: LIPID PROFILE
16. Cholesterol, Triglycerides, HDL, LDL, Lipids
Normal: Cholesterol 150-250 | TG 65-165 | HDL >60 | LDL <130 mg/dL
Cholesterol Synthesis (Mevalonate Pathway - in liver):
Acetyl-CoA + Acetyl-CoA → Acetoacetyl-CoA → HMG-CoA
↓ [HMG-CoA Reductase - RATE LIMITING, target of STATINS]
Mevalonate
↓ [multiple steps via squalene]
Cholesterol
Lipoprotein Transport Cycle:
LIVER:
Cholesterol + TG packaged into VLDL
↓ [Lipoprotein lipase in capillaries - breaks down TG]
IDL (Intermediate)
↓ [more TG removed]
LDL (most cholesterol-rich particle)
↓ [LDL receptor on cells - LDLR, discovered by Brown & Goldstein]
Cells take up LDL via endocytosis → cholesterol used for membranes, hormones, bile acids
REVERSE CHOLESTEROL TRANSPORT (HDL does this):
Peripheral cells → cholesterol → loaded onto HDL (via ABCA1 transporter)
↓ [LCAT: lecithin-cholesterol acyltransferase - esterifies cholesterol in HDL]
HDL matures → delivers cholesterol back to liver → bile excretion
Why LDL/Cholesterol RAISED:
- Familial hypercholesterolemia (genetic LDL receptor deficiency - most severe)
- Hypothyroidism (↓ LDL receptor expression)
- Nephrotic syndrome (↑ hepatic lipoprotein synthesis as compensation for protein loss)
- Cushing's syndrome, obesity, Type 2 DM
- High saturated fat diet
Why Triglycerides RAISED:
- Diabetes (excess glucose → converted to TG via lipogenesis)
- Alcohol (inhibits beta-oxidation → TG accumulate in liver → VLDL overproduction)
- Hypothyroidism, renal failure
- Familial hypertriglyceridemia
- Acute pancreatitis (cause AND consequence)
Why HDL LOWERED (bad - less reverse cholesterol transport):
- Smoking, obesity, physical inactivity, Type 2 DM, metabolic syndrome
- Beta-blockers, anabolic steroids
PART 5: SPECIFIC ENZYMES
17. LDH (Lactate Dehydrogenase)
Normal: 240-480 U/L
Purpose: Nonspecific marker of tissue/cell destruction (found in virtually every tissue).
Enzyme Function - Links Anaerobic Glycolysis to Aerobic Metabolism:
Under ANAEROBIC conditions (no oxygen, e.g. exercise, ischemia):
Pyruvate + NADH → Lactate + NAD⁺
[LDH - M4 isoform in skeletal muscle]
This regenerates NAD⁺ → allows glycolysis to continue even without oxygen
Under AEROBIC conditions (heart, resting muscle):
Lactate + NAD⁺ → Pyruvate + NADH
[LDH - H4 isoform in heart]
Pyruvate then enters Krebs cycle for full oxidation
LDH Isoenzymes (5 tetramers of H and M subunits):
| Isoenzyme | Subunit | Main Tissue | Clinical Use |
|---|
| LDH-1 (H₄) | 4H | Heart, RBCs | Myocardial infarction, hemolysis |
| LDH-2 (H₃M₁) | 3H, 1M | Heart, RBCs | MI (LDH-1 > LDH-2 = "flipped" pattern in MI) |
| LDH-3 (H₂M₂) | 2H, 2M | Lung, lymph nodes | Lymphoma, pulmonary embolism |
| LDH-4 (H₁M₃) | 1H, 3M | Liver, skeletal muscle | Hepatitis, muscle injury |
| LDH-5 (M₄) | 4M | Liver, skeletal muscle | Hepatitis, rhabdomyolysis |
Why RAISED: MI (LDH-1 rises 12-24 hrs, peaks 48-72 hrs, remains elevated 7-10 days - useful when troponin test is delayed), hemolysis, hepatitis, lymphoma, pulmonary embolism, renal infarction, megaloblastic anemia, tumor necrosis, stroke.
Why LOWERED: Not clinically significant.
18. CPK (Creatine Phosphokinase) / CK
Purpose: Marker of muscle damage - skeletal and/or cardiac.
Enzyme Function - Energy Storage in Muscle:
At rest (energy surplus):
Creatine + ATP → Creatine phosphate + ADP
[Creatine kinase - stores energy]
During sudden muscle activity (before aerobic metabolism catches up):
Creatine phosphate + ADP → Creatine + ATP
[Creatine kinase - rapid ATP generation, first ~10 seconds of intense activity]
CK Isoforms:
| Isoform | Subunits | Source | Clinical Significance |
|---|
| CK-MM | 2M | Skeletal muscle (97%) | Rhabdomyolysis, muscular dystrophy, polymyositis, strenuous exercise, IM injections |
| CK-MB | 1M+1B | Cardiac muscle (~30% of cardiac CK) | Acute MI - rises 4-6 hrs, peaks 24 hrs, normalizes 48-72 hrs. Useful for reinfarction detection |
| CK-BB | 2B | Brain, smooth muscle | Stroke, brain injury, bowel infarction |
Why CPK RAISED:
- Cardiac: MI (CK-MB most diagnostic)
- Skeletal muscle: rhabdomyolysis (crush injury, seizures, malignant hyperthermia), muscular dystrophy (very high, lifelong), polymyositis/dermatomyositis, hypothyroidism (very high), statin-induced myopathy, vigorous exercise, IM injections
- Brain: stroke, head injury
Why CPK LOWERED: Reduced muscle mass, prolonged bed rest, steroids (cause muscle atrophy)
19. CKMB (CK-MB isoenzyme)
Already detailed above. Specifically for cardiac injury detection:
- Rises: 4-6 hours after MI
- Peaks: 18-24 hours
- Returns to normal: 48-72 hours
- If CK-MB rises again after normalizing → reinfarction (advantage over troponin which stays elevated for days)
- CK-MB >5% of total CK = cardiac source
PART 6: PANCREATIC ENZYMES
20. Sr. Amylase
Normal: 25-125 U/L
Purpose: Tests for pancreatic disease, primarily acute pancreatitis. Less specific because it has multiple sources.
Enzyme Function:
Dietary starch (amylose + amylopectin - alpha-1,4 and alpha-1,6 glycosidic bonds)
↓ [Salivary amylase begins digestion in mouth]
↓ [Pancreatic amylase acts in duodenum - main digestive amylase]
Maltose + Maltotriose + Alpha-limit dextrins
↓ [Maltase, isomaltase on brush border]
Glucose → absorbed
Sources: Pancreatic acinar cells (P-amylase) and salivary glands (S-amylase)
Kinetics in Pancreatitis:
- Rises: within 2-12 hours of onset
- Peaks: ~24 hours
- Returns to normal: 3-5 days (short half-life - limitation)
- Specificity: 70% (less specific because salivary glands, fallopian tubes, and bowel also produce amylase)
Why RAISED:
- Acute pancreatitis (most important cause)
- Chronic pancreatitis (acute exacerbation)
- Salivary gland disease: mumps, parotitis, Sjogren's syndrome
- Bowel obstruction, bowel ischemia, peritonitis
- Ectopic pregnancy, ovarian cysts
- Renal failure (decreased excretion of amylase)
- Macroamylasemia (amylase bound to immunoglobulin - persistently elevated but no disease)
Why LOWERED:
- Chronic pancreatitis with exocrine insufficiency (acinar cells destroyed → no enzyme production)
- Cystic fibrosis (pancreatic duct obstruction/destruction)
21. Sr. Lipase
Normal: 0-60 U/L
Purpose: More specific and sensitive marker for acute pancreatitis than amylase. Gold standard pancreatic enzyme test.
Enzyme Function:
Dietary triglycerides (fats) enter duodenum from stomach
↓
Pancreatic lipase (secreted by pancreatic acinar cells)
+ Colipase (cofactor - displaces bile salts from fat droplet surface, gives lipase access)
+ Bile salts (from liver - emulsify fat droplets, increase surface area)
↓
Triglycerides → 2 Fatty acids + 1 Monoacylglycerol
↓
Absorbed by enterocytes → packaged as chylomicrons → lymph → blood
Why lipase is BETTER than amylase for pancreatitis:
- Produced only by pancreatic acinar cells (no salivary source) → more specific
- Stays elevated longer: 7-14 days vs 3-5 days for amylase - catches late presenters
- Not affected by macroamylasemia
- Lipase >3x upper limit of normal = strong evidence for acute pancreatitis
Why RAISED:
- Acute pancreatitis (most important - >3x ULN is diagnostic)
- Chronic pancreatitis (acute flares)
- Pancreatic duct obstruction (gallstone in ampulla, carcinoma of pancreatic head)
- Pancreatic trauma
- Renal failure (decreased excretion)
- Intestinal ischemia/bowel perforation
- Drugs: opioids (cause sphincter of Oddi spasm → bile/pancreatic duct pressure rises)
Why LOWERED:
- Chronic pancreatitis with exocrine insufficiency
- Cystic fibrosis
- Pancreatic resection/total pancreatectomy
PART 7: SEROLOGY MARKERS
22. HIV (Anti-HIV Antibody / p24 Antigen)
Purpose: Screen for Human Immunodeficiency Virus infection.
What it tests: 4th generation tests detect both anti-HIV antibodies (IgM/IgG, appear 3-12 weeks after infection) AND p24 antigen (HIV core protein, detectable earlier - within 2 weeks). Window period: 2-4 weeks.
Why positive: Active HIV infection
Confirmatory test: Western blot or HIV-1/2 differentiation assay
23. HCV (Anti-HCV Antibody)
Purpose: Screen for Hepatitis C virus infection.
What it tests: Anti-HCV antibodies (IgG). Window period: 8-11 weeks.
- A positive test means past or current infection - does NOT distinguish between the two
- Confirmatory: HCV RNA (PCR) - detects active virus
Why relevant: HCV causes chronic hepatitis → cirrhosis → hepatocellular carcinoma. Major cause of elevated transaminases.
24. HBsAg (Hepatitis B Surface Antigen)
Purpose: Detects active/current Hepatitis B infection.
Hepatitis B Serological Markers - The Full Picture:
| Marker | What it means |
|---|
| HBsAg (+) | Active infection (acute or chronic) - present from 1-6 months |
| HBsAb/Anti-HBs (+) | Immunity - either recovered from infection or vaccinated |
| HBcAb IgM (+) | Recent/acute infection |
| HBcAb IgG (+) | Past infection (or window period) |
| HBeAg (+) | High viral replication - highly infectious |
| HBeAb (+) | Seroconversion - lower replication |
Why HBsAg checked: HBV causes acute and chronic hepatitis, cirrhosis, hepatocellular carcinoma. Explains elevated LFTs.
25. VDRL (Venereal Disease Research Laboratory)
Purpose: Screen for syphilis (Treponema pallidum).
What it tests: Non-treponemal test - detects reagin antibodies (IgG/IgM against cardiolipin-lecithin-cholesterol antigen). A surrogate marker, not specific.
Confirmatory test: TPHA (Treponema Pallidum Haemagglutination Assay) or FTA-ABS - directly detects anti-treponemal antibodies.
False positives: Pregnancy, SLE, antiphospholipid syndrome, malaria, leprosy, TB, IV drug use, old age (biological false positive - BFP)
Stages of Syphilis:
- Primary: Painless chancre (hard, indurated, non-tender ulcer at inoculation site)
- Secondary: Diffuse rash (including palms/soles - pathognomonic), condylomata lata, mucous patches
- Tertiary: Gummas, cardiovascular syphilis (aortic regurgitation, aortitis), neurosyphilis (tabes dorsalis, general paresis of insane)
- Latent: No symptoms, but VDRL positive
SUMMARY TABLE - All Investigations at a Glance
| Investigation | Main Purpose | Key Enzyme/Mediator | Raised By | Lowered By |
|---|
| Hb | O₂ capacity | ALA synthase (heme synthesis) | Polycythemia, altitude | Anemia (iron def, hemolysis, blood loss) |
| WBC | Immunity | Myeloperoxidase (neutrophils) | Infection, leukemia | Viral infection, chemo, HIV |
| Platelets | Primary hemostasis | COX-1 → TXA₂ (activation) | Reactive thrombocytosis | ITP, DIC, aplastic anemia |
| ESR | Inflammation screen | None (physical sedimentation) | Inflammation, myeloma | Polycythemia, sickle cell |
| BSL | Glucose status | PFK-1 (glycolysis RLS) | DM, steroids, pancreatitis | Insulin excess, Addison's |
| BUL/BUN | Kidney excretion / liver synthesis | Urea cycle (CPS I - RLS) | Renal failure, dehydration | Liver failure, malnutrition |
| Creatinine | GFR / kidney function | Creatine kinase (muscle) | CKD, AKI, rhabdomyolysis | Low muscle mass, pregnancy |
| Na⁺ | Osmolality, fluid balance | Na/K-ATPase, Aldosterone | Dehydration, Conn's | SIADH, Addison's, CCF |
| K⁺ | Cardiac/nerve membrane potential | Na/K-ATPase, Aldosterone | Renal failure, Addison's | Diuretics, vomiting, insulin |
| SGOT/AST | Hepatocellular injury | AST (Vit B6 cofactor) | Hepatitis, MI, alcohol | B6 deficiency, end-stage liver |
| SGPT/ALT | Hepatocellular injury (liver-specific) | ALT (Vit B6 cofactor) | Viral hepatitis, drugs, NAFLD | B6 deficiency, uremia |
| Total Bilirubin | Liver processing of Hb breakdown | UGT1A1 (conjugation), Heme oxygenase | Hemolysis, hepatitis, obstruction | Not clinically significant |
| Albumin | Liver synthetic function / oncotic pressure | Hepatocyte synthesis | Dehydration | Cirrhosis, nephrotic, malnutrition |
| Globulin | Immune proteins | Immunoglobulin synthesis | Chronic infection, myeloma | Immunodeficiency |
| ALP | Cholestasis / bone disease | ALP (phosphate hydrolysis) | Bile obstruction, bone disease, pregnancy | Hypothyroidism, zinc deficiency |
| PT | Extrinsic coagulation pathway | Thrombin, Fibrinase (Factor XIII) | Liver disease, Vit K deficiency, warfarin | Not measured as "low" |
| BT | Platelet function | COX-1, vWF | Thrombocytopenia, aspirin, von Willebrand | N/A |
| Cholesterol | Cardiovascular risk | HMG-CoA reductase (RLS) | Hypothyroidism, nephrotic, FH | Liver disease, malabsorption |
| TG | Metabolic syndrome / pancreatitis risk | Lipoprotein lipase | DM, alcohol, hypothyroidism | Malnutrition |
| HDL | Cardioprotective ("good") | LCAT (matures HDL) | Exercise, statins | Smoking, DM, metabolic syndrome |
| LDH | Nonspecific tissue damage | LDH (pyruvate ⇌ lactate) | MI, hemolysis, lymphoma, hepatitis | Not significant |
| CPK | Muscle injury | Creatine kinase | MI, rhabdomyolysis, hypothyroidism | Reduced muscle mass |
| CK-MB | Cardiac muscle injury | CK-MB isoform | MI specifically | Reduced cardiac mass |
| Amylase | Pancreatic / salivary disease | Pancreatic + salivary amylase | Acute pancreatitis, mumps | Chronic pancreatic insufficiency |
| Lipase | Pancreatic disease (specific) | Pancreatic lipase + colipase | Acute pancreatitis, duct obstruction | Pancreatic insufficiency, CF |
| HIV | HIV infection | - | Active HIV | - |
| HCV | Hepatitis C | - | HCV infection | - |
| HBsAg | Hepatitis B (active) | - | Active HBV | - |
| VDRL | Syphilis | - | Syphilis, SLE (false +ve) | - |
Sources: Miller's Anesthesia 10th Ed; Basic Medical Biochemistry 6th Ed; Henry's Clinical Diagnosis & Management by Laboratory Methods; Sleisenger & Fordtran's GI and Liver Disease; Harrison's Principles of Internal Medicine 22nd Ed; Ganong's Review of Medical Physiology 26th Ed